EDP Sciences logo
Search
Menu
All issues Volume 34 / No 4 (July-August 2003) Vet. Res., 34 4 (2003) 405-411 References
Free Access
Issue
Vet. Res.
Volume 34, Number 4, July-August 2003
Page(s) 405 - 411
DOI https://doi.org/10.1051/vetres:2003011
How to cite this article Vet. Res. (2003) 405-411
  1. Anadòn A., Reeve-Johnson L., Macrolide antibiotics, drug interactions and microsomal enzymes: implication for veterinary medicine, Res. Vet. Sci. 66 (1999) 197-203 [CrossRef] [PubMed].
  2. Belman S., The fluorimetric determination of formaldehyde, Anal. Chim. Acta 29 (1963) 120-126 [CrossRef].
  3. Bensoussan C., Delaforge M., Mansuy D., Particular ability of cytochrome P450 3A to form inhibitory P450-iron-metabolite complexes upon metabolic oxidation of aminodrugs, Biochem. Pharmacol. 49 (1995) 591-602 [CrossRef] [PubMed].
  4. Cerrone A., Monetti D.M., Mariani F., Menna L.F., Bartoli M., Fioretti A., L'impiego degli antibiotici nell'allevamento cunicolo intensivo : protocolli terapeutici e farmaco-resistenza, Rivista Italiana di Coniglicoltura 11-12 (1999) 47-54.
  5. Colin M., La cuniculture européenne, Cuniculture 26 (1991) 299-301.
  6. Daujat M., Pichard L., Fabre I., Pineau T., Fabre G., Bonfils C., Maurel P., Induction protocols for cytochrome P450IIIA in vivo and in primary cultures of animal and human hepatocytes, Methods Enzymol. 26 (1991) 345-357.
  7. Delaforge M., Jaouen M., Bouille G., Inhibitory metabolite complex formation of meth-ylenedioxymethamphetamine with rat and human cytochrome P450. Particular involvement of CYP 2D, Environ. Toxicol. Pharmacol. 7 (1999) 153-158.
  8. Eeckhoutte C., Giuliano Albo A., Carletti M., Rossetto Giaccherino A., Galtier P., Nebbia C., Dacasto M., Time-dependent variations of drug-metabolising enzymes activities (DMEs) in primary cultures of rabbit hepatocytes. Toxicol. In Vitro 16 (2002) 375-382.
  9. Franklin M.R., Cytochrome P450 metabolic intermediate complexes from macrolide antibiotics and related compounds, Methods Enzymol. 26 (1991) 559-573.
  10. Laemmli U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227 (1970) 680-685 [CrossRef] [PubMed].
  11. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J., Protein measurement with the folin phenol reagent, J. Biol. Chem. 293 (1951) 265-275.
  12. Maurel P., The CYP3 family, in: Ioannides C. (Ed), Cytochromes P450: metabolic and toxicological aspects, CRC Press, Boca Raton, 1996, pp. 241-270.
  13. Nebbia C., Ceppa L., Dacasto M., Carletti M., Nachtmann C., Oxidative metabolism of monensin in rat liver microsomes and interaction with tiamulin and other chemotherapeutic agents: evidence for the involvement of the cytochrome P450 3A subfamily, Drug Metab. Dispos. 27 (1999) 1039-1044 [PubMed].
  14. Nebbia C., Ceppa L., Dacasto M., Nachtmann C., Carletti M., Oxidative monensin metabolism and cytochrome P450 3A content and functions in liver microsomes from horses, pigs, broiler chicks, cattle and rats, J. Vet. Pharmacol. Ther. 24 (2001) 399-403 [PubMed].
  15. Nebbia C., Dacasto M., Rossetto Giaccherino A., Giuliano Albo A., Carletti M., Comparative expression of liver cytochrome P450-dependent monooxygenases in the horse and in other agricultural and laboratory species, Vet. J. 165 (2003) 495-513 [CrossRef].
  16. Pai M.P., Graci D.M., Amsden G.W., Macrolide drug interactions: an update, Ann. Pharmacother. 34 (2000) 495-513 [CrossRef] [PubMed].
  17. Reidy G.F., Mehta I., Murray M., Inhibition of oxidative drug metabolism by orphenadrine: in vitro and in vivo evidence for isozyme specific complexation of cytochrome P450 and inhibition kinetics, Mol. Pharmacol. 35 (1989) 736-743 [PubMed].
  18. Reidy G.F., Murray M., Evidence for complexation of P450 IIC6 by an orphenadrine metabolite, Biochem. Biophys. Res. Commun. 166 (1990) 772-779 [CrossRef] [PubMed].
  19. Roos P.H., Golub-Ciosk B., Kallweit P., Kauczinski D., Hanstein W.G., Formation of ligand and metabolite complexes as a means for selective quantitation of cytochrome P450 isozymes, Biochem. Pharmacol. 45 (1993) 2239-2250 [CrossRef] [PubMed].
  20. Rutten A.A.J.J.L., Falke H.E., Catsburg J.F., Topp R., Blaauboer B.J., van Holstein I., Doorn L., van Leeuwen F.X.R., Interlaboratory comparison of total cytochrome P-450 and protein determinations in rat liver microsomes, Arch. Toxicol. 61 (1987) 27-33 [CrossRef] [PubMed].
  21. Towbin H., Staehelin T., Gordon G., Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications, Proc. Natl. Acad. Sci. USA 76 (1979) 4350-4354 [CrossRef] [PubMed].
  22. Witkamp R.F., Nijmeijer S.M., Monshouwer M., van Miert A.S.J.P.A.M., The antibiotic tiamulin is a potent inducer and inhibitor of cytochrome P4503A via the formation of a stable metabolic intermediate complex. Studies in primary hepatocyte cultures and liver microsomes of the pig, Drug Metab. Dispos. 23 (1995) 542-547 [PubMed].
  23. Yamasaki H., Shimada T., Comparative studies of in vitro inhibition of cytochrome P450 3A4-dependent testosterone 6b-hydroxylation by roxithromycin and its metabolites, troleandomycin, and erythromycin, Drug Metab. Dispos. 26 (1998) 1053-1057 [PubMed].
  24. Zweers-Zeilmaker W.M., Van Miert A.S.J.P. A.M., Horbach G.J., Witkamp R.F., In vitro complex formation and inhibition of hepatic cytochrome P450 activity by different macrolides and tiamulin in goats and cattle, Res. Vet. Sci. 66 (1998) 51-55 [CrossRef].